Point-of-care Devices: the Next Frontier in Personalized Chemotherapy

Overview

Journal Future Sci OA

Specialty Biotechnology

Date 2017 Sep 9

PMID 28884015

Citations 1

Authors

Maria Amelia Carlos Souto Maior Borba

Carlos Henrique Madeiros Castelletti

Jose Luiz de Lima Filho

Danyelly Bruneska Gondim Martins

Affiliations

Soon will be listed here.

Citing Articles

Point-of-care optical spectroscopy platform and ratio-metric algorithms for rapid and systematic functional characterization of biological models .

Hasan M, Yan J, Zhu C J Biomed Opt. 2025; 29(12):125002.

PMID: 39741576 PMC: 11687633. DOI: 10.1117/1.JBO.29.12.125002.

References

Kalia M . Biomarkers for personalized oncology: recent advances and future challenges. Metabolism. 2014; 64(3 Suppl 1):S16-21. DOI: 10.1016/j.metabol.2014.10.027. View

Syedmoradi L, Daneshpour M, Alvandipour M, Gomez F, Hajghassem H, Omidfar K . Point of care testing: The impact of nanotechnology. Biosens Bioelectron. 2016; 87:373-387. DOI: 10.1016/j.bios.2016.08.084. View

Borba M, Melo-Neto R, Leitao G, Castelletti C, Lima-Filho J, Bg Martins D . Evaluating the impact of missenses mutations in CYP2D6*7 and CYP2D6*14A: does it compromise tamoxifen metabolism?. Pharmacogenomics. 2016; 17(6):573-82. DOI: 10.2217/pgs-2015-0003. View

Patani H, Bunney T, Thiyagarajan N, Norman R, Ogg D, Breed J . Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use. Oncotarget. 2016; 7(17):24252-68. PMC: 5029699. DOI: 10.18632/oncotarget.8132. View

Schork N . Personalized medicine: Time for one-person trials. Nature. 2015; 520(7549):609-11. DOI: 10.1038/520609a. View

Housman G, Byler S, Heerboth S, Lapinska K, Longacre M, Snyder N . Drug resistance in cancer: an overview. Cancers (Basel). 2014; 6(3):1769-92. PMC: 4190567. DOI: 10.3390/cancers6031769. View

Kartal-Yandim M, Adan-Gokbulut A, Baran Y . Molecular mechanisms of drug resistance and its reversal in cancer. Crit Rev Biotechnol. 2015; 36(4):716-26. DOI: 10.3109/07388551.2015.1015957. View

Buhagiar A, Ayers D . Chemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastoma. Anal Cell Pathol (Amst). 2015; 2015:150634. PMC: 4516851. DOI: 10.1155/2015/150634. View

Calabria D, Caliceti C, Zangheri M, Mirasoli M, Simoni P, Roda A . Smartphone-based enzymatic biosensor for oral fluid L-lactate detection in one minute using confined multilayer paper reflectometry. Biosens Bioelectron. 2017; 94:124-130. DOI: 10.1016/j.bios.2017.02.053. View

10.

Markman M, Luce R . Impact of the cost of cancer treatment: an internet-based survey. J Oncol Pract. 2010; 6(2):69-73. PMC: 2835484. DOI: 10.1200/JOP.091074. View

11.

Ciccolini J, Fanciullino R, Serdjebi C, Milano G . Pharmacogenetics and breast cancer management: current status and perspectives. Expert Opin Drug Metab Toxicol. 2015; 11(5):719-29. DOI: 10.1517/17425255.2015.1008447. View

12.

Wang M, Hu L, Xu C . Recent advances in the design of polymeric microneedles for transdermal drug delivery and biosensing. Lab Chip. 2017; 17(8):1373-1387. DOI: 10.1039/c7lc00016b. View